Paolo Bironzo Selected Research

Paolo Bironzo Research Topics

Disease

21	Neoplasms (Cancer) 08/2022 - 04/2012
17	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2022 - 04/2012
9	Lung Neoplasms (Lung Cancer) 01/2022 - 05/2018
7	Malignant Mesothelioma 04/2022 - 11/2018
4	Mesothelioma 08/2022 - 11/2018
3	Adenocarcinoma of Lung 12/2022 - 01/2021
3	Disease Progression 05/2021 - 02/2016
3	Prostatic Neoplasms (Prostate Cancer) 01/2018 - 12/2013
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 05/2021 - 02/2016
2	Sarcoma (Soft Tissue Sarcoma) 01/2021 - 12/2014
2	Pleurisy (Pleuritis) 01/2021 - 01/2019
2	Neoplasm Metastasis (Metastasis) 01/2021 - 11/2020
2	Colorectal Neoplasms (Colorectal Cancer) 05/2018 - 01/2017
1	COVID-19 01/2022
1	Lung Diseases (Lung Disease) 08/2021
1	Genetic Predisposition to Disease (Genetic Predisposition) 05/2021
1	Melanoma (Melanoma, Malignant) 01/2021
1	Solitary Fibrous Tumors 01/2021
1	Synovial Sarcoma (Synovioma) 01/2021
1	Fasciitis (Fascitis) 01/2021
1	Fibroma (Fibromatosis) 01/2021
1	Hemangiosarcoma (Angiosarcoma) 01/2021
1	Aggressive Fibromatosis (Desmoid) 01/2021
1	Hyperplasia 01/2021
1	Leiomyosarcoma 01/2021
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2021
1	Circulating Neoplastic Cells 12/2020
1	Infections 01/2020
1	Pulmonary Arterial Hypertension 01/2019
1	Hypoxia (Hypoxemia) 05/2018
1	Nausea 04/2018
1	Vomiting 04/2018
1	Leukemia 02/2016

Drug/Important Bio-Agent (IBA)

13	Immune Checkpoint InhibitorsIBA 12/2022 - 09/2017
5	Pharmaceutical PreparationsIBA 01/2022 - 02/2016
4	Biomarkers (Surrogate Marker)IBA 05/2022 - 01/2017
3	Pemetrexed (MTA)FDA Link 08/2022 - 11/2018
3	Thymidylate SynthaseIBA 08/2022 - 01/2021
3	ErbB Receptors (EGF Receptor)IBA 05/2022 - 07/2012
3	Cisplatin (Platino)FDA LinkGeneric 02/2022 - 04/2012
3	AsbestosIBA 05/2021 - 11/2018
3	Tyrosine Kinase InhibitorsIBA 05/2021 - 12/2014
3	pembrolizumabIBA 01/2021 - 09/2019
3	abirateroneIBA 01/2018 - 12/2013
2	Proteins (Proteins, Gene)FDA Link 08/2022 - 08/2022
2	Biological ProductsIBA 01/2022 - 09/2021
2	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 09/2021 - 01/2021
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 09/2021 - 01/2021
2	PlatinumIBA 05/2021 - 04/2012
2	B7-H1 AntigenIBA 01/2021 - 11/2020
2	Carboplatin (JM8)FDA LinkGeneric 04/2018 - 02/2016
2	AndrogensIBA 01/2018 - 12/2013
2	enzalutamideIBA 01/2018 - 12/2015
2	Hormones (Hormone)IBA 01/2018 - 12/2013
2	DNA (Deoxyribonucleic Acid)IBA 03/2015 - 04/2012
1	MicroRNAs (MicroRNA)IBA 08/2022
1	Thioredoxin-Disulfide ReductaseIBA 05/2022
1	Codon (Codons)IBA 05/2022
1	defactinibIBA 05/2022
1	pevonedistatIBA 02/2022
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2022
1	PM 01183IBA 05/2021
1	niraparibIBA 01/2021
1	durvalumabIBA 01/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2021
1	1-methyl-1-piperidinomethane sulfonateIBA 01/2021
1	dostarlimabIBA 01/2021
1	InterferonsIBA 01/2021
1	Anaplastic Lymphoma KinaseIBA 12/2020
1	Circulating Tumor DNAIBA 12/2020
1	CD4 Antigens (CD4 Antigen)IBA 01/2019
1	Immunoglobulins (Immunoglobulin)IBA 01/2019
1	Insulin-Like Growth Factor I (IGF-1)IBA 01/2019
1	MucinsIBA 01/2019
1	Growth Hormone-Releasing Hormone (Somatotropin Releasing Hormone)IBA 01/2019
1	Har(29)- Arg(28) Nle(27) Orn(21) His(20) Orn(12,) Abu(15) His(11) Tyr(Me)(10) Har(9) Ala(8) Fpa(5,6) Arg(2) (PhAc-Ada)(0)-Tyr(1) GHRH(1-29)NH2IBA 01/2019
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2019
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019
1	MIA-690IBA 01/2019
1	Peptides (Polypeptides)IBA 12/2018
1	HLA Antigens (Human Leukocyte Antigens)IBA 12/2018
1	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 11/2018
1	CytokinesIBA 05/2018
1	Thymidine PhosphorylaseIBA 05/2018
1	pyrimidineIBA 05/2018
1	Leucovorin (Folinic Acid)FDA Link 05/2018
1	EnzymesIBA 05/2018
1	Dexamethasone (Maxidex)FDA LinkGeneric 04/2018
1	Neurokinin-1 Receptor AntagonistsIBA 04/2018
1	5-HT3 Serotonin Receptors (5 HT3 Receptor)IBA 04/2018
1	Abiraterone AcetateIBA 01/2018
1	Androgen Antagonists (Antiandrogens)IBA 01/2018
1	Etoposide (VP 16)FDA LinkGeneric 02/2016
1	Sunitinib (Sutent)FDA Link 02/2016

Therapy/Procedure

11	Drug Therapy (Chemotherapy) 08/2022 - 04/2012
10	Therapeutics 02/2022 - 07/2012
8	Immunotherapy 12/2022 - 12/2018
2	Castration 01/2018 - 12/2015
1	Nutritional Support (Artificial Feeding) 01/2022
1	Combination Drug Therapy (Combination Chemotherapy) 08/2019